JP2009502797A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009502797A5 JP2009502797A5 JP2008522911A JP2008522911A JP2009502797A5 JP 2009502797 A5 JP2009502797 A5 JP 2009502797A5 JP 2008522911 A JP2008522911 A JP 2008522911A JP 2008522911 A JP2008522911 A JP 2008522911A JP 2009502797 A5 JP2009502797 A5 JP 2009502797A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- isolated peptide
- group
- cupredoxin
- residues
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70029705P | 2005-07-19 | 2005-07-19 | |
| US11/244,105 US7691383B2 (en) | 2004-10-07 | 2005-10-06 | Cupredoxin derived transport agents and methods of use thereof |
| US76474906P | 2006-02-03 | 2006-02-03 | |
| US11/436,592 US7381701B2 (en) | 2001-02-15 | 2006-05-19 | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins |
| PCT/US2006/027940 WO2007024368A2 (en) | 2005-07-19 | 2006-07-19 | Compositions and methods to control angiogenesis with cupredoxins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009502797A JP2009502797A (ja) | 2009-01-29 |
| JP2009502797A5 true JP2009502797A5 (cg-RX-API-DMAC7.html) | 2009-09-10 |
Family
ID=37772089
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008522911A Pending JP2009502797A (ja) | 2005-07-19 | 2006-07-19 | 血管形成をキュプレドキシンで制御するための組成物および方法 |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1904081A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2009502797A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20080034905A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2006284490A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0615555A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2615560A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL188691A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2008000993A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20080829L (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007024368A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8158574B2 (en) * | 2004-10-07 | 2012-04-17 | Cdg Therapeutics, Inc. | Compositions and methods to prevent cancer with cupredoxins |
| EP2061498A4 (en) * | 2006-09-14 | 2009-11-04 | Univ Illinois | COMPOSITIONS AND METHOD FOR CANCER PREPARATION WITH CUPREDOXINES |
| AU2007329375A1 (en) | 2006-12-04 | 2008-06-12 | The Board Of Trustees Of The University Of Illinois | Compositions and methods to treat cancer with cupredoxins and CpG rich DNA |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7491394B2 (en) * | 2001-02-15 | 2009-02-17 | The Board Of Trustees Of The University Of Illinois | Cytotoxic factors for modulating cell death |
| UA97466C2 (ru) * | 2004-10-07 | 2012-02-27 | Ананда Чакрабарти | Транспортирующие соединения - производные купредоксина и способы их применения |
| AU2006277009A1 (en) * | 2005-05-20 | 2007-02-15 | The Board Of Trustees Of The University Of Illinois | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins |
| JP2008545398A (ja) * | 2005-05-20 | 2008-12-18 | ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ | キュプレドキシンおよびシトクロムcを用いてhiv感染を治療するための組成物および方法 |
| AU2006251742A1 (en) * | 2005-05-20 | 2006-11-30 | The Board Of Trustees Of The University Of Illinois | Compositions and methods for treating malaria with cupredoxin and cytochrome |
-
2006
- 2006-07-19 WO PCT/US2006/027940 patent/WO2007024368A2/en not_active Ceased
- 2006-07-19 AU AU2006284490A patent/AU2006284490A1/en not_active Abandoned
- 2006-07-19 BR BRPI0615555-3A patent/BRPI0615555A2/pt not_active IP Right Cessation
- 2006-07-19 MX MX2008000993A patent/MX2008000993A/es active IP Right Grant
- 2006-07-19 CA CA002615560A patent/CA2615560A1/en not_active Abandoned
- 2006-07-19 EP EP06787787A patent/EP1904081A4/en not_active Withdrawn
- 2006-07-19 JP JP2008522911A patent/JP2009502797A/ja active Pending
- 2006-07-19 KR KR1020087002477A patent/KR20080034905A/ko not_active Ceased
-
2008
- 2008-01-09 IL IL188691A patent/IL188691A0/en unknown
- 2008-02-15 NO NO20080829A patent/NO20080829L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA3231953A1 (en) | Compositions and methods for the treatment of metabolic and liver disorders | |
| TWI282282B (en) | Method for treating pain by peripheral administration of a neurotoxin | |
| RU2009113812A (ru) | Композиции и способы для профилактики рака с помощью купредоксинов | |
| CN109379888B (zh) | 包含带有羧酸根电荷和疏水性基团的共聚氨基酸的可注射溶液 | |
| RU2009125599A (ru) | Композиции и способы лечения рака cpg-богатой днк и купредоксинами | |
| JP2010503409A5 (cg-RX-API-DMAC7.html) | ||
| JP2006501820A5 (cg-RX-API-DMAC7.html) | ||
| JP2018123169A (ja) | ヘプシジン類似体及びその使用 | |
| RU2009133473A (ru) | Композиции и способы для предотвращения рака с помощью купредоксинов | |
| JP6738739B2 (ja) | 膀胱内滴下注入用生物製剤 | |
| CN108472329B (zh) | 多肽刺激免疫系统的用途 | |
| EA039105B1 (ru) | Катионные нейротоксины | |
| GB2327675A (en) | Nicotinic acid amide derivatives | |
| JP2008535805A5 (cg-RX-API-DMAC7.html) | ||
| CN117298254A (zh) | 用于口服递送生物活性货物的cholix毒素衍生的融合分子 | |
| ZA200300313B (en) | Chemokine receptor modulators, production and use. | |
| CA3221611A1 (en) | Long-acting dual gip/glp-1 peptide conjugates and methods of use | |
| CA2795168A1 (en) | Factor xii inhibitors for treating interstitial lung disease | |
| BR112013006088B1 (pt) | Construto de entrega isolado, e, composição farmacêutica | |
| CN103372199A (zh) | 一种预防和治疗神经退行性疾病的新型脑部靶向制剂 | |
| BRPI0810384B1 (pt) | terapia enzimática anticâncer | |
| JP2015500823A (ja) | Glp−1アゴニスト | |
| TW202140074A (zh) | Fgf-21結合物調配物 | |
| CN102149725A (zh) | 用于抑制g2细胞周期停滞和使细胞对dna损伤剂敏感的cbp501衍生制剂及基于其的方法 | |
| US20130035294A1 (en) | Neuromedin and FN-38 Peptides for Psychotic Diseases |